Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Dermoscopy helps diagnose syphilitic alopecia, and treatment with penicillin can regrow hair.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Dissecting cellulitis of the scalp is a condition that causes inflammation and scarring on the scalp, mainly affecting African-American men, and can lead to permanent hair loss.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Secretome-based therapies could improve hair growth better than current treatments.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

White hair patch repigmented and hair regrew in a balding patient after treatment with exosomes and laser.

The conclusion is that a brown halo around hair follicles, seen in rapid hair loss, might be linked to inflammation or chemical exposure.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Using micrografts with stem cells and platelet-rich plasma can safely and effectively help regrow hair.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.

Early diagnosis and quick treatment improve life quality for FFA patients.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Micrografts improve hair density and thickness without side effects.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.